We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Policy

Cannabis Policy

Colorado Announces New THC Testing Rules for Hemp Products

Some of the requirements are stricter than the equivalent rules for cannabis products.

Read More

Pennsylvania Expands Medical Cannabis Regulations

The bill also permits cannabis companies to remediate their products by extracting them into a topical form should they be contaminated with yeast or mold.

Read More

New Colorado Law Restricts Concentrate Sales

Coming into effect on January 1, 2022, the bill will limit patients aged 21 and over to 8 grams of concentrates per purchase, down from the previous limit of 40 grams.

Read More

Mexico’s Supreme Court Decriminalizes Cannabis

Mexico’s Supreme Court has removed the laws prohibiting the use of recreational cannabis, effectively decriminalizing the drug for adults.

Read More

UN Calls for Ban on Cannabis Advertising

The World Drug Report 2021 from the UN’s Office on Drugs and Crime (UNODC) claims that such a ban would “ensure that public health interests prevail over business interests.”

Read More

Young Cannabis Consumers Experience More Suicidal Thoughts, Study Finds

Suicidal thoughts are on the rise among young people in the US, and cannabis may have something to do with it, according to a new study.

Read More

Why the DEA’s New Marijuana Rule Is “the Most Meaningful Cannabis Reform in Decades”

A recent change at the DEA will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself, according to cultivators and industry experts.

Read More

Connecticut Legalizes Recreational Cannabis

After weeks of anticipation, the governor of Connecticut has signed the state’s recreational cannabis legalization bill, effectively legalizing marijuana from July 1.

Read More

UK Government Advised to Move Regulation of Cannabinoids from Home Office to the Department of Health

Instead, according to a new report, the licensing system should be run by the UK’s Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency (MHRA).

Read More

 
Advertisement